Although the authors of the study did not characterize the stem cell markers in melanoma, based on the data obtained, a cautious conclusion can be drawn that pravastatin promotes the increase in the activity of the ABCB1 channel and thus, indirectly, tumour growth. The gene discussed is ABCB1; the disease is melanoma.